The therapeutic potential of thyrotropin releasing hormone (TRH) in Alzheimer's disease (AD)

This publication has 22 references indexed in Scilit:

• EFFECT ON WEAKNESS AND SPASTICITY IN AMYOTROPHIC LATERAL SCLEROSIS OF THYROTROPIN-RELEASING HORMONE
  The Lancet, 1983
• Post mortem levels of thyrotropin-releasing hormone and neurotensin in the amygdala in Alzheimer's disease, schizophrenia and depression
  Journal of the Neurological Sciences, 1983
• Regulatory peptides as a source of new drugs — the clinical prospects for analogues of TRH which are resistant to metabolic degradation
  Brain Research Reviews, 1982
• Treatment of Alzheimer's Disease: A Cautionary Note
  New England Journal of Medicine, 1981
• Physostigmine and Arecoline: Effects of Intravenous Infusions in Alzheimer Presenile Dementia
  The British Journal of Psychiatry, 1981
• Thyrotropin-releasing hormone has multiple actions in cortex
  Brain Research, 1980
• Effects of physostigmine and lecithin on memory in Alzheimer disease
  Annals of Neurology, 1979
• Pre- and postsynaptic neurochemical alterations in Alzheimer's disease
  Brain Research, 1978
• NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIA
  The Lancet, 1977
• SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
  Published by Elsevier ,1976